Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The development of a plant-based vaccine for measles

Identifieur interne : 004331 ( PascalFrancis/Checkpoint ); précédent : 004330; suivant : 004332

The development of a plant-based vaccine for measles

Auteurs : D. E. Webster [Australie] ; M. C. Thomas [Australie] ; Z. Huang [Australie] ; S. L. Wesselingh [Australie]

Source :

RBID : Pascal:06-0198087

Descripteurs français

English descriptors

Abstract

Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:06-0198087

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">The development of a plant-based vaccine for measles</title>
<author>
<name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The The Baker Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0198087</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0198087 INIST</idno>
<idno type="RBID">Pascal:06-0198087</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004452</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C43</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">004331</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004331</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">The development of a plant-based vaccine for measles</title>
<author>
<name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The The Baker Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Measles</term>
<term>Vaccination</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Vaccin</term>
<term>Vaccination</term>
<term>Rougeole</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Vaccin</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0264-410X</s0>
</fA01>
<fA02 i1="01">
<s0>VACCDE</s0>
</fA02>
<fA03 i2="1">
<s0>Vaccine</s0>
</fA03>
<fA05>
<s2>23</s2>
</fA05>
<fA06>
<s2>15</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>The development of a plant-based vaccine for measles</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG">
<s1>Plant-derived vaccines and antibodies: Potential and limitations</s1>
</fA09>
<fA11 i1="01" i2="1">
<s1>WEBSTER (D. E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>THOMAS (M. C.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HUANG (Z.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>WESSELINGH (S. L.)</s1>
</fA11>
<fA12 i1="01" i2="1">
<s1>ARNTZEN (Charles)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>DODET (Betty)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1">
<s1>HAMMOND (Rose)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1">
<s1>KARASEV (Alexander)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1">
<s1>RUSSELL (Michael)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="06" i2="1">
<s1>PLOTKIN (Stanley)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01">
<s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA15 i1="01">
<s1>Arizona State University</s1>
<s2>Tempe</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02">
<s1>University of Pennsylvania, Philadelphia</s1>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA15>
<fA15 i1="03">
<s1>Dodet Bioscience, 66 cours Charlemagne</s1>
<s2>69002 Lyon</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1">
<s1>Fondation Mérieux</s1>
<s2>69002 Lyon</s2>
<s3>FRA</s3>
<s9>patr.</s9>
</fA18>
<fA20>
<s1>1859-1865</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20289</s2>
<s5>354000133094310200</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>06-0198087</s0>
</fA47>
<fA60>
<s1>P</s1>
<s2>C</s2>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Vaccine</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05F04</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B05C02B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Vaccin</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Vaccine</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Vacuna</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Vaccination</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Vaccination</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Vacunación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Rougeole</s0>
<s5>14</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Measles</s0>
<s5>14</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sarampión</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fN21>
<s1>121</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
<pR>
<fA30 i1="01" i2="1" l="ENG">
<s1>Plant-derived vaccines and antibodies: Potential and limitations. Meeting</s1>
<s3>Veyrier-du-Lac FRA</s3>
<s4>2004-03-21</s4>
</fA30>
</pR>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
</noRegion>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004331 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 004331 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:06-0198087
   |texte=   The development of a plant-based vaccine for measles
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024